Comparison in pathological behaviours & prognosis of gastric cancers from general hospitals between China & Japan

Indian Journal of Medical Research

Volumn 132, Issue 9, 2010, Pages 295-302

  Yu, Miao ^a   Zheng, Hua Chuan ^a   Xia, Pu ^a   Takahashi, Hiroshi ^b   Masuda, Shinji ^c   Takano, Yasuo ^b   Xu, Hui Mian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b KANAGAWA CANCER CENTER   (Japan)

^c Kouseiren Takaoka Hospital   (Japan)

Author keywords

China; Gastric cancer; Japan; Patholobiological behaviours; Prognosis

Indexed keywords

PARAFFIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CHINA; CONTROLLED STUDY; FEMALE; GENERAL HOSPITAL; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAPAN; JAPANESE; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PERITONEUM METASTASIS; PROGNOSIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; STOMACH CANCER; SURVIVAL RATE; TUMOR VOLUME; AGE; CLASSIFICATION; COMPARATIVE STUDY; HISTOLOGY; INCIDENCE; MORTALITY; NONPARAMETRIC TEST; PATHOLOGY; STATISTICS; STOMACH TUMOR;

AGE FACTORS; CHINA; FEMALE; HISTOLOGICAL TECHNIQUES; HUMANS; INCIDENCE; JAPAN; MALE; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; STOMACH NEOPLASMS;

EID: 77957042893     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol 2003; 56: 1-9.
2. Zheng HC, Takahashi H, Murai Y, Cui ZG, Nomoto K, Miwa S, et al. Upregulated EMMPRIN/ CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis. Br J Cancer 2006; 95: 1371-8.
3. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006; 12: 354-62.
4. Fayçal J, Bessaguet C, Nousbaum JB, Cauvin JM, Cholet F, Bideau K, et al. Epidemiology and long term survival of gastric carcinoma in the French district of Finistere between 1984 and 1995. Gastroenterol Clin Biol 2005; 29: 23-32.
5. Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, Goh KL, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 2008; 9: 279-87.
6. Inoue M, Tsugane S. Epidemiology of gastric cancer in Japan. Postgrad Med J 2005; 81: 419-24.
7. Riddell RH, Iwafuchi M. Problems arising from eastern and western classification systems for gastrointestinal dysplasia and carcinoma: are they resolvable? Histopathology 1998; 33: 197-202.
8. You WC, Li JY, Zhang L, Jin ML, Chang YS, Ma JL, et al. Etiology and prevention of gastric cancer: a population study in a high risk area of China. Chin J Dig Dis 2005; 6: 149-54.
9. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291: 187-194.
10. Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol 2006; 12: 17-20.
11. Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med 1995; 333: 32-41.
12. Tahara E. Genetic pathways of two types of gastric cancer. IARC Sci Publ 2004; 157: 327-49.
13. Murai Y, Zheng HC, Abdel Aziz HO, Mei H, Kutsuna T, Nakanishi Y., et al. High JC virus load in gastric cancer and adjacent non-cancerous mucosa. Cancer Sci 2007; 98: 25-31.
14. Sobin LH, Wittekind C, editors. TNM classification of malignant tumours, 6th ed. New Jersey: John Wiley & Sons; 2002.
15. Fenoglio-Preiser C, Munoz N, Carneiro F, Powell SM, Correa P, Rugge M, et al. Gastric carcinoma. In: Hamilton SR, Aaltonen LA, editors. WHO classification of tumors: pathology and genetics of tumors of the digestive system. Lyon: IARC Press; 2000. p. 39-50.
16. Murakami T. Pathomorphological diagnosis. Definition and gross classification of early gastric cancer. Gann Monogr Cancer Res 1971; 11: 53.
17. Zheng HC, Li XH, Hara T, Masuda S, Yang XH, Guan YF, et al. Mixed-type gastric carcinomas exhibit more aggressive features and indicate the histogenesis of carcinomas. Virchows Arch 2008; 452: 525-534.
18. Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Miwa S, et al. Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray. J Clin Pathol 2007; 60: 273-277.
19. Roukos DH, Agnantis NJ, Fatouros M, Kappas AM. Gastric cancer: introduction, pathology, epidemiology. Gastric Breast Cancer 2002; 1: 1-3.
20. Lindblad M, Ye W, Rubio C, Lagergren J. Estrogen and risk of gastric cancer: a protective effect in a nationwide cohort study of patients with prostate cancer in Sweden. Cancer Epidemiol Biomarkers Prev 2004; 13: 2203-2207.
21. Kamino H, Tam S, Roses D, Toussaint S. Elastic fiber pattern in regressing melanoma: a histochemical and immunohistochemical study. J Cutan Pathol 2010; 37: 723-729.
22. Zheng HC, Takahashi H, Li XH, Hara T, Masuda S, Guan YF, et al. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas. Hum Pathol 2008; 39: 1042-1049.
23. Zheng HC, Takahashi H, Li XH, Hara T, Masuda S, Guan YF, et al. Downregulated parafibromin expression is a promising marker for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas. Virchows Arch 2008; 452: 147-155.
24. Zheng HC, Tsuneyama K, Takahashi H, Miwa S, Sugiyama T, Popivanova BK, et al. Aberrant Pim-3 expression is involved in gastric adenoma-adenocarcinoma sequence and cancer progression. J Cancer Res Clin Oncol 2008; 134: 481-488.
25. Yu M, Zheng H, Tsuneyama K, Takahashi H, Nomoto K, Xu H, et al. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression. Hum Pathol 2007; 38: 1248-1255.
26. Zheng H, Takahashi H, Nakajima T, Murai Y, Cui Z, Nomoto K, et al. MUC6 down-regulation correlates with gastric carcinoma progression and a poor prognosis: an immunohistochemical study with tissue microarrays. J Cancer Res Clin Oncol 2006; 132: 817-823.
27. Zhang WF. Strategy in the surgical treatment of early gastric cancer. J Surg Concept Pract 2003; 8: 7-9.